Literature DB >> 22211122

Oncology Practice Trends From the National Practice Benchmark, 2005 through 2010.

Thomas R Barr1, Elaine L Towle.   

Abstract

Oncology Metrics, a division of Altos Solutions, has been conducting organized surveys of practicing oncologists since 2005. In this article, we present data that represent trends in community oncology practice over a 6-year period, 2005 to 2010, and make projections on the basis of these data. Over the next 3 years, operating margins will continue to decrease, gains in business and clinical operating efficiencies will slow, and labor costs will rise. The cost of drugs provided to patients is also increasing while the amount above cost that is being reimbursed continues a slow decline. The gap between practice costs and practice revenue will continue to narrow, and as this occurs, community oncology practices will find it difficult to maintain their current business models.

Entities:  

Year:  2011        PMID: 22211122      PMCID: PMC3170058          DOI: 10.1200/JOP.2011.000389

Source DB:  PubMed          Journal:  J Oncol Pract        ISSN: 1554-7477            Impact factor:   3.840


  5 in total

1.  2009 national practice benchmark: report on 2008 data.

Authors:  Elaine L Towle; Thomas R Barr
Journal:  J Oncol Pract       Date:  2009-09       Impact factor: 3.840

2.  Key practice indicators in office-based oncology practices: 2007 report on 2006 data.

Authors:  John Akscin; Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2007-07       Impact factor: 3.840

3.  The 2007 national practice benchmark: results of a national survey of oncology practices.

Authors:  Thomas R Barr; Elaine L Towle; William M Jordan
Journal:  J Oncol Pract       Date:  2008-07       Impact factor: 3.840

4.  National practice benchmark: 2010 report on 2009 data.

Authors:  Elaine L Towle; Thomas R Barr
Journal:  J Oncol Pract       Date:  2010-09       Impact factor: 3.840

5.  National oncology practice benchmark: an annual assessment of financial and operational parameters-2010 report on 2009 data.

Authors:  Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2011-03       Impact factor: 3.840

  5 in total
  9 in total

1.  Commentary: six years of trends in oncology practice data.

Authors:  Douglas W Blayney
Journal:  J Oncol Pract       Date:  2011-09       Impact factor: 3.840

2.  Oncology professional services agreements: a model for hospital affiliation that preserves private practice.

Authors:  Michael L Blau
Journal:  J Oncol Pract       Date:  2012-03       Impact factor: 3.840

3.  Oncology practice trends from the national practice benchmark.

Authors:  Thomas R Barr; Elaine L Towle
Journal:  J Oncol Pract       Date:  2012-09       Impact factor: 3.840

4.  Problems with public reporting of cancer quality outcomes data.

Authors:  Paul Goldberg; Rena M Conti
Journal:  J Oncol Pract       Date:  2014-05       Impact factor: 3.840

5.  National trends in pancreatic cancer outcomes and pattern of care among Medicare beneficiaries, 2000 through 2010.

Authors:  Yun Wang; Deborah Schrag; Gabriel A Brooks; Francesca Dominici
Journal:  Cancer       Date:  2013-12-30       Impact factor: 6.860

6.  The 340B drug discount program: hospitals generate profits by expanding to reach more affluent communities.

Authors:  Rena M Conti; Peter B Bach
Journal:  Health Aff (Millwood)       Date:  2014-10       Impact factor: 6.301

Review 7.  The Advanced Practitioner and Collaborative Practice in Oncology.

Authors:  Sandra E Kurtin; Mary Peterson; Paige Goforth; Megan Brafford May; Pamela Hallquist Viale; Wendy J Smith; Deborah Rust; Carolyn Grande; Nancy M Nix; Catherine S Bishop
Journal:  J Adv Pract Oncol       Date:  2015-11-01

Review 8.  Increasing use of advanced practitioners: strategizing for the future.

Authors:  Pamela Hallquist Viale
Journal:  J Adv Pract Oncol       Date:  2014-01

Review 9.  Benchmarking facilities providing care: An international overview of initiatives.

Authors:  Frédérique Thonon; Jonathan Watson; Mahasti Saghatchian
Journal:  SAGE Open Med       Date:  2015-09-23
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.